Tell your healthcare provider if you have any heart conditions, especially if you have had a heart attack or anything that requires /viewarticle/936115 types of foods may affect how your body absorbs RYTARY. Or, you may sprinkle the entire contents of both halves of the Indicated for Parkinson disease, postencephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxicationMaintain patients on the lowest dosage required to achieve symptomatic control and to minimize adverse reactions such as dyskinesia and nauseaDuopa: Extended-release enteral solution for indicated for treatment of motor fluctuations in patients with advanced Parkinson diseaseAdminister enteral suspension by intrajejunal infusion over a 16-hrIndividualize daily dose by taking into consideration the morning dose, continuous dose, and extra doses that a patient is takingMaximum daily dose 2000 mg of the levodopa component (ie, 1 cassette/day) administered over 16 hr; at the end of the daily 16-hr infusion, patients will disconnect the pump from jejunal tubing and take their night-time dose of oral immediate-release carbidopa-levodopa tabletsRenal impairment: Safety and efficacy not established; use with cautionHepatic impairment: Safety and efficacy not established; use with cautionConcurrent administration of nonselective monoamine oxidase inhibitors (MAOIs) or use within last 14 daysUse caution in history of MI with residual atrial, nodal, or ventricular arrhythmias, peptic ulcer, or seizureUse caution in severe cardiovascular, respiratory disease, renal, hepatic, or endocrine disease; monitor disease parametersUse caution in bronchial asthma patients taking sympathomimeticsLevodopa may cause patients to fall asleep while engaging in activities of daily living; caution regarding use of machinery and drivingAvoid use in patients with a major psychotic disorder; therapy may exacerbate psychosis; increases risk for hallucinations and development of psychosis; other psychiatric symptoms include decreased impulse control and compulsive behaviors, depression, and suicidality; observe patients for symptoms of depression with concomitant suicidal tendenciesMay exacerbate dyskinesia; reduce dose to control symptomsPeripheral neuropathy reported with use; evaluate patients for history of neuropathyand known risk factors prior to initiating therapy; assess patients for peripheral neuropathy periodically during therapyOrthostatic hypotension may occur (more common with immediate-release formulation)Use caution in patients with glaucoma; monitor intraocular pressure carefully; some formulations are conraindicated in patients with narrow-angle glaucomaObserve patients carefully if discontinued abruptly; risk of syndrome resembling neuroleptic malignant syndromeControlled-release formulation is less bioavailable than conventional formulationGastrointestinal complications from PEG-J or naso-jejunal tube can occur (eg, abscess, bezoar, ileus, jntussusception, implant site erosion/ulcer, intestinal hemorrhage, intestinal ischemia, intestinal obstruction, intestinal perforation, pancreatitis, peritonitis, pneumonia, including aspiration pneumonia, pneumoperitoneum, and post-operative wound infection) sepsis; these complications may result in serious outcomes (eg,need for surgery, death)Parkinson disease patients are at increased risk of developing melanoma; monitor patients closely and perform periodic skin examinationsThere are no adequate data on developmental risk associated with use in pregnant womenLevodopa has been detected in human milk after administration of drug; there are no data on presence of carbidopa in human milk, effects of levodopa or carbidopa on breastfed infant, or on milk production; however, inhibition of lactation may occur because levodopa decreases secretion of prolactin in humans; carbidopa is excreted in rat milkDevelopmental and health benefits of breastfeeding should be considered along with mother’s clinical need for therapy and any potential adverse effects on breastfed infant from therapy or from underlying maternal conditionA: Generally acceptable.